The Exercise Prescription: Redefining the Standard of Care Across the Oncology Continuum

For decades, the oncology community prioritized rest for patients undergoing active treatment. However, recent data—including a landmark 2026 pooled analysis in JAMA Network Open—has catalyzed a paradigm shift, repositioning exercise as a potent clinical intervention rather than a lifestyle adjunct.

This video package explores the clinical translation of exercise oncology through 3 expert lenses. We begin with the epidemiological evidence, highlighting findings that post-diagnosis moderate-to-vigorous physical activity is associated with significant reductions in cancer-specific mortality. Critically, these benefits extend beyond commonly studied malignancies to include lung, ovarian, endometrial, and bladder cancers. The data confirms that even patients who were sedentary prior to diagnosis can improve their survival outcomes by adopting an active lifestyle during and after treatment.

Moving into the clinical window, Drs Tracy Crane and LaShae Rolle discuss their meta-analysis on exercise during chemotherapy. Their findings suggest a synergistic benefit to aerobic and resistance training, though aerobic exercise remains a primary driver for improving quality of life. Rolle, speaking from both a researcher’s and survivor’s perspective, advocates for a "staggered" exercise prescription that accounts for the peak toxicity days following infusion while maintaining a steady uptick in intensity.

A central theme of the discussion is the fatigue paradox. While cancer-related fatigue often feels like a barrier to movement, experts emphasize that exercise is the primary evidence-based treatment to mitigate it. Furthermore, emerging research suggests exercise may enhance treatment tolerance, potentially helping patients remain on life-saving therapies longer by managing toxicities.

The package concludes with a call for structured implementation. Oncology physical therapist Karen Hock highlights the importance of formal PT referrals to bridge the gap between clinical data and patient confidence. The message is clear: exercise is a foundational component of modern oncology care.

REFERENCES

1. Rees-Punia E, Teras LR, Newton CC, et al. Leisure-Time Physical Activity and Cancer Mortality Among Cancer Survivors. JAMA Netw Open. 2026 Feb 2;9(2):e2556971. doi: 10.1001/jamanetworkopen.2025.56971. PMID: 41701497; PMCID: PMC12914486.

2. Rolle LD, Ahn S, Mezzio EM, et al. The impact of exercise interventions on domains of quality of life in women diagnosed with breast cancers during chemotherapy treatment: a meta-analytic review. Lancet Healthy Longev. 2026 Feb;7(2):100819. doi: 10.1016/j.lanhl.2026.100819. Epub 2026 Feb 25. PMID: 41763228.